Key Insights

Highlights

Treatment Research

2 treatments under study, led by Pagetex Pdt

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03713203Not ApplicableRecruiting

PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV).

Showing all 1 trials

Research Network

Common Treatments

  • Pagetex Pdt1
  • Methyl Aminolevulinate1

Active Sponsors

  • Centre Hospitalier Universitaire De Lille1
  • Galderma R&D1
  • Institut National de la Santé Et de la Recherche Médicale, France1
  • University Hospital, Lille1

Top Investigators

Related Conditions

  • Paget Disease Extramammary1
  • Paget Disease Of The Vulva1

Activity Timeline